GGrantIndex
Sort

141,003 grants matching cytokine

Aerobic Capacity, Depression, & Inflammatory Responsivity in Cancer Survivors

$612,145
Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2019 · CA

Mechanistic evaluation of mast cell agonists combined with TLR, NOD and STING agonists.

$612,133
Kristy M Ainslie · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI

In vivo studies of megakaryocyte microRNAs regulating platelet number and integrin activation

$612,123
Paul F. Bray · University Of Utah · R01 · FY2021 · HL

In vivo studies of megakaryocyte microRNAs regulating platelet number and integrin activation

$612,123
Paul F. Bray · University Of Utah · R01 · FY2020 · HL

Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi

$612,118
Linden T Hu · Tufts University Boston · R01 · FY2020 · AI

Biomarkers and Genetic Factors Related to Sarcopenia in Women

$612,099
Zhao Chen · University Of Arizona · R01 · FY2007 · AG

Host Factors Influencing HIV Viral Load and Infectivity in Semen

$612,052
Christopher D Pilcher · University Of California, San Francisco · R01 · FY2016 · HD

Host Immune Responses to Chlamydia trachomatis Candidate Vaccine Antigens and their Association with Clinical Correlates of Protective Immunity in Women

$612,050
William M Geisler · University Of Alabama At Birmingham · R01 · FY2024 · AI

JAK Inhibition in Down Syndrome

$612,030
Joaquin M. Espinosa · University Of Colorado Denver · R61 · FY2021 · AR

Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice

$611,942
Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES

Development of P2Y Receptor Ligands

$611,928
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Phase 2 Proof-of-Concept Efficacy of BT-11 in Crohn's Disease Patients

$611,918
Simon Lichtiger · Landos Biopharma, Inc. · R01 · FY2020 · DK

Anti-inflammatory therapy to improve outcomes in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplant (TPIAT)

$611,913
Melena D. Bellin · University Of Minnesota · R01 · FY2016 · DK

Functions of Regulatory Motifs in Signaling Networks

$611,895
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · GM

Functions of Regulatory Motifs in Signaling Networks

$611,895
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · GM

Functions of Regulatory Motifs in Signaling Networks

$611,895
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · GM

Age-associated Innate Immune Dysfunction in Chronic Rhinosinusitis

$611,877
Justin H Turner · Vanderbilt University Medical Center · R01 · FY2020 · AG

Age-associated Innate Immune Dysfunction in Chronic Rhinosinusitis

$611,877
Justin H Turner · Vanderbilt University Medical Center · R01 · FY2021 · AG

Who are the Ultra-positive, culture-negative? Understanding the trajectories of individuals in Uganda with trace M. tuberculosis nucleic acid in sputum

$611,836
Emily A Kendall · Johns Hopkins University · R01 · FY2021 · HL

Biomarkers and Genetic Factors Related to Sarcopenia in Women

$611,813
Zhao Chen · University Of Arizona · R01 · FY2010 · AG

Impact of HSV-2 on Female Genital Tract Mucosal Immunity & HIV Infection

$611,790
Betsy C. Herold · Albert Einstein College Of Medicine · R01 · FY2014 · AI

Anti-inflammatory therapy to improve outcomes in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplant (TPIAT)

$611,757
Melena D. Bellin · University Of Minnesota · R01 · FY2018 · DK

Immune correlates of acute HBV recovery with and without HIV

$611,631
Chloe L Thio · Johns Hopkins University · R01 · FY2019 · AI

Laboratory of Oral Connective Tissue Biology

$611,628
Martha Somerman · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2021 · AR

Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens

$611,615
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2020 · CA